ISTANBUL, July 08, 2025 (GLOBE NEWSWIRE) -- LivMedCell has officially launched a groundbreaking research collaboration with ...

Chicago-based physician announces expansion of charitable programs focused on healthcare access and community wellness ...

The U.S. pilot study, now underway at Johns Hopkins, builds on the strong early data from Australia. Combined insights from ...

Earlier this year, Purespring announced that the European Medicines Agency (EMA) had granted orphan drug designation to PS-002 for the treatment of patients with IgAN. This designation followed the ...

The securities described above are being offered pursuant to an automatic shelf registration statement on Form S-3ASR (File No. 333-269707), which was filed with the Securities and Exchange Commission ...

Transforming Healthcare Ltd, a leader in healthcare consultancy and innovation, has announced the global launch of the Healthcare Convergence Framework® (HCF), the world’s first AI/Robotics Readiness ...

About PhenQ PhenQ is a multi-action fat burning supplement available over the counter, backed by clinical studies and endorsed by more than 800 medical practitioners. It is designed to support women ...

Dr. Patel’s decision to partner with Heald signals a growing recognition that the future of chronic disease care lies not in more apps or prescriptions, but in empowering people with data, support, ...

Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced the closing of a registered direct offering with accredited investors for ...

Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialized life sciences company dedicated to the research and development of therapeutics for ...

Company completes refinancing of all existing senior secured debt through a $120 million self-syndicated term loan with leading banks, at an interest rate of 8.3% ---- Company ...

ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory ...